Overview
Properties
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab9575 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| Functional Studies | FuncS: Use at an assay dependent dilution. |
| SDS-PAGE | SDS-PAGE: Use at an assay dependent dilution. |
Protein info
-
Alternative names
- C11orf43FLJ22066FLJ44734
- IGF 2IGF IIIGF-IIIGF2IGF2_HUMANIGFIIINSIGFInsulin like Growth Factor 2insulin like growth factor 2 (somatomedin A)Insulin like growth factor IIInsulin like growth factor II precursorInsulin like growth factor type 2Insulin-like Growth Factor 2Insulin-like Growth Factor 2pp9974Preptinputative insulin like growth factor II associated proteinSomatomedin ASomatomedin ASomatomedin-A
see all
Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3.
modificationsO-glycosylated with a core 1 or possibly core 8 glycan.
Target information above from: UniProt accession
P01344
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
IGF2 protein (Active) images
References for IGF2 protein (Active) (ab9575)
This product has been referenced in:
- Suvasini R et al. Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2. J Biol Chem 286:25882-90 (2011). Read more (PubMed: 21613208) »
